Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessEarningsMarksans Pharma reports profit of Rs 4.3 crore in March quarter

    Marksans Pharma reports profit of Rs 4.3 crore in March quarter

    The board has recommended dividend of 5 percent per equity share of Re 1 each for the financial year 2017-18.

    Moneycontrol News
    May 30, 2018 / 13:33 IST
    Myth 3: Everyone who has a mental illness needs medication to manage symptoms | Bulthuis says no two patients are the same. While medicines can help manage symptoms, there are some people with mental illness who do not require medication. For others, medicine is essential for recovery. (Representative image)
       
       
      26 Aug, 2025 12:21
      Volume
      Todays L/H
      More

      Marksans Pharma has reported profit in the quarter ended March 2018. The company's Q4 net profit was at Rs 4.3 crore against loss of Rs 2.4 crore in a year ago period.

      Revenue of the company was up 61 percent at Rs 87 crore versus Rs 54 crore.

      EBITDA or the operating profit was at Rs 10.7 crore and margin was up at 12.3 percent.

      The board has recommended dividend of 5 percent per equity share of Re 1 each for the financial year 2017-18.

      At 13:18 hrs Marksans Pharma was quoting at Rs 31.10, up Rs 0.40, or 1.30 percent.

      Moneycontrol News
      first published: May 30, 2018 01:33 pm

      Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

      Subscribe to Tech Newsletters

      • On Saturdays

        Find the best of Al News in one place, specially curated for you every weekend.

      • Daily-Weekdays

        Stay on top of the latest tech trends and biggest startup news.

      Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347